REFERENCES
- Nakao M, Yokota S, Iwai T, Internal tandem duplication of the FLT3 gene found in acute myeloid leukemia. Leukemia. 1996;10(12):1911–1918.
- Gilliland DG, Griffin JD. The roles of FLT3 in hematopoiesis and leukemia. Blood. 2002;100(5):1532–1542.
- Ozeki K, Kiyoi H, Hirose Y, Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia. Blood. 2004;103(5):1901–1908.
- Kang HJ, Hong SH, Kim IH, Prognostic significance of FLT3 mutations in pediatric non-promyelocytic acute myeloid leukemia. Leuk Res. 2005;29(6):617–623.
- Meshinchi S, Alonzo TA, Stirewalt DL, Clinical implications of FLT3 mutations in pediatric AML. Blood. 2006;108(12):3654–3661.
- Shimada A, Taki T, Tabuchi K, Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: a study of the Japanese childhood AML Cooperative Study Group. Pediatr Blood Cancer. 2008;50(2):264–269.
- Ahmad F, Mandava S, Das BR. Analysis of FLT3-ITD and FLT3-Asp835 mutations in de novo acute myeloid leukemia: evaluation of incidence, distribution pattern, correlation with cytogenetics and characterization of internal tandem duplication from Indian population. Cancer Invest. 2010;28(1):63–73.
- Ghosh K, Swaminathan S, Madkaikar M, FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India. Ann Hematol. 2012;91(11):1703–1712.
- Sazawal S, Kumar B, Hasan SK, Haematological & molecular profile of acute myelogenous leukaemia in India. Ind J Med Res. 2009;129(3):256–261.
- Vora HH, Shukla SN, Brahambhatt BV, Clinical relevance of FLT3 receptor protein expression in Indian patients with acute leukemia. Asia-Pacific J Clin Oncol. 2010:6(4):306–319.
- Brown P, Alonzo TA, Gerbling RB, High level expression of wild type FLT3 is associated with poor outcome and selective sensitivity to FLT3 inhibitors in childhood acute myeloid leukemia: a children's oncology group study. ASH Ann Meeting Abst. 2008;112:147.
- Grimwade D, Walker H, Oliver F, The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 1998:92(7):2322–2333.
- Sharawat SK, Bakhshi R, Vishnubhatla S, BAX/BCL2 RMFI ratio predicts better induction response in pediatric patients with acute myeloid leukemia. Pediatr Blood Cancer. 2013:60(8):E63-66. doi: 10.1002/pbc.24518.
- Sharawat SK, Gupta R, Raina V, Increased co-expression of c-KIT and FLT-3 receptors on myeloblasts: independent predictor of poor outcome in pediatric acute myeloid leukemia. Cytometry B. 2013 ( in press).
- Meshinchi S, Woods WG, Stirewalt DL, Prevalence and prognostic significance of FLT3 internal tandem duplication in pediatric acute myeloid leukemia. Blood. 2001;97(1):89–94.